Opportunistic Infections Clinical Trial
Official title:
Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome in Lambaréné, Gabon
The objective of this project is to determine clinical and biological predictors of Immune Reconstitution Inflammatory Syndrome (IRIS) occurrence in HIV infected patients who are started on antiretroviral therapy (ART), and to obtain more insight into the pathogenesis of this syndrome. The investigators will prospectively study HIV infected patients in Sub Saharan Africa who will be initiated on ART and are at risk to develop IRIS in all its different appearances. In these patients, the investigators will assess the value of clinical features and plasma biomarkers to predict IRIS, and the investigators will obtain insight into which inflammatory pathways become activated during IRIS. This project will provide novel knowledge about this clinically highly relevant healthcare problem in a resource poor setting, namely in Lambaréné, Gabon, in the Central African rainforest belt. In Gabon little research has been done in the field of HIV. The epidemiological pattern of IRIS in Gabon will be described. Promising putative plasma biomarkers will be validated for their use in daily practice.
n/a
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02454569 -
Vicente Ferrer HIV Cohort Study
|
||
| Completed |
NCT02942173 -
CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT
|
Phase 2/Phase 3 | |
| Recruiting |
NCT02982902 -
T Cell Therapy of Opportunistic Cytomegalovirus Infection
|
Early Phase 1 | |
| Not yet recruiting |
NCT01541631 -
A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
|
N/A | |
| Completed |
NCT03087890 -
Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria
|
Phase 4 | |
| Active, not recruiting |
NCT00814827 -
Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma
|
||
| Recruiting |
NCT03798301 -
Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells
|
Phase 1 | |
| Completed |
NCT00137657 -
Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance
|
Phase 4 | |
| Active, not recruiting |
NCT05694546 -
Re-engagement at Discharge 2
|
N/A | |
| Recruiting |
NCT02337595 -
Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation
|
Phase 1/Phase 2 | |
| Completed |
NCT03083756 -
Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients
|
N/A | |
| Completed |
NCT00001477 -
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
|
N/A | |
| Completed |
NCT05349383 -
Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities
|